69 related articles for article (PubMed ID: 21389974)
1. Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across species.
Patel-Chamberlin M; Wang Y; Satirapoj B; Phillips LM; Nast CC; Dai T; Watkins RA; Wu X; Natarajan R; Leng A; Ulanday K; Hirschberg RR; Lapage J; Nam EJ; Haq T; Adler SG
Kidney Int; 2011 May; 79(10):1138-48. PubMed ID: 21389974
[TBL] [Abstract][Full Text] [Related]
2. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells.
Satirapoj B; Wang Y; Chamberlin MP; Dai T; LaPage J; Phillips L; Nast CC; Adler SG
Nephrol Dial Transplant; 2012 Jul; 27(7):2702-11. PubMed ID: 22167593
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal disease.
Pahl MV; Vaziri ND; Yuan J; Adler SG
Clin J Am Soc Nephrol; 2010 Jan; 5(1):56-61. PubMed ID: 19833906
[TBL] [Abstract][Full Text] [Related]
4. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
[TBL] [Abstract][Full Text] [Related]
5. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury.
Bonventre JV
Scand J Clin Lab Invest Suppl; 2008; 241():78-83. PubMed ID: 18569971
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P.
Bandari PS; Qian J; Yehia G; Joshi DD; Maloof PB; Potian J; Oh HS; Gascon P; Harrison JS; Rameshwar P
Regul Pept; 2003 Mar; 111(1-3):169-78. PubMed ID: 12609765
[TBL] [Abstract][Full Text] [Related]
7. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
Waring WS; Moonie A
Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies.
Vlasakova K; Erdos Z; Troth SP; McNulty K; Chapeau-Campredon V; Mokrzycki N; Muniappa N; Gu YZ; Holder D; Bailey WJ; Sistare FD; Glaab WE
Toxicol Sci; 2014 Mar; 138(1):3-20. PubMed ID: 24361871
[TBL] [Abstract][Full Text] [Related]
9. Urine periostin as a biomarker of renal injury in chronic allograft nephropathy.
Satirapoj B; Witoon R; Ruangkanchanasetr P; Wantanasiri P; Charoenpitakchai M; Choovichian P
Transplant Proc; 2014; 46(1):135-40. PubMed ID: 24507039
[TBL] [Abstract][Full Text] [Related]
10. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
12. Performance of the chronic kidney disease-epidemiology study equations for estimating glomerular filtration rate before and after nephrectomy.
Lane BR; Demirjian S; Weight CJ; Larson BT; Poggio ED; Campbell SC
J Urol; 2010 Mar; 183(3):896-901. PubMed ID: 20083272
[TBL] [Abstract][Full Text] [Related]
13. High expression of neutrophil gelatinase-associated lipocalin (NGAL) in the kidney proximal tubules of diabetic rats.
Liu F; Yang H; Chen H; Zhang M; Ma Q
Adv Med Sci; 2015 Mar; 60(1):133-8. PubMed ID: 25661178
[TBL] [Abstract][Full Text] [Related]
14. Parenchymal injury in remnant-kidney model may be linked to apoptosis of renal cells mediated by nitric oxide.
Hruby Z; Rosinski M; Tyran B
J Nephrol; 2008; 21(5):686-93. PubMed ID: 18949723
[TBL] [Abstract][Full Text] [Related]
15. Kidney injury biomarkers and urinary creatinine variability in nominally healthy adults.
Stiegel MA; Pleil JD; Sobus JR; Angrish MM; Morgan MK
Biomarkers; 2015; 20(6-7):436-52. PubMed ID: 26616147
[TBL] [Abstract][Full Text] [Related]
16. Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats.
Tonomura Y; Uehara T; Yamamoto E; Torii M; Matsubara M
Toxicology; 2011 Dec; 290(2-3):241-8. PubMed ID: 22005293
[TBL] [Abstract][Full Text] [Related]
17. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
18. Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes.
Brott DA; Furlong ST; Adler SH; Hainer JW; Arani RB; Pinches M; Rossing P; Chaturvedi N;
Drug Des Devel Ther; 2015; 9():3191-8. PubMed ID: 26124642
[TBL] [Abstract][Full Text] [Related]
19. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
[TBL] [Abstract][Full Text] [Related]
20. Effects of Stevia rebaudiana (Bertoni) extract and N-nitro-L-arginine on renal function and ultrastructure of kidney cells in experimental type 2 Diabetes.
Ozbayer C; Kurt H; Kalender S; Ozden H; Gunes HV; Basaran A; Cakmak EA; Civi K; Kalender Y; Degirmenci I
J Med Food; 2011 Oct; 14(10):1215-22. PubMed ID: 21663490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
